The inaugural Lee Health Research Day on March 11 was like “a science fair for doctors.” ...
Dealbreaker on MSN6d
Beam Base Editor’s Early Data in Rare Liver Disease Tee Up $500M Stock Sale in Tough MarketA Beam Therapeutics gene-editing therapy designed to fix a mutation at the root of a rare liver protein deficiency now has early signs of efficacy along with safety data that ease some concerns about ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback